From the Journals

CVD risk high in individuals who once had metabolically healthy obesity

View on the News

Metabolically healthy obesity not so healthy after all

While obesity has inherent adverse effects on cardiometabolic parameters and cardiovascular disease (CVD) risk factors, metabolically healthy obesity (MHO) has emerged as a categorization of obese individuals who may not be at increased CVD risk because of relatively normal levels of lipids, blood pressure, and glucose.

An increasing body of research, however, including the present study by Dr. Mongraw-Chaffin and colleagues, highlights “dangers and long-term outcomes” of the MHO phenotype, Dr. Prakash Deedwania and Dr. Carl J. Lavie wrote in an editorial.

The analysis of 6,809 individuals in the Multi-Ethic Study of Atherosclerosis found that MHO is not a stable condition, as almost one-half of individuals developed metabolic syndrome over 12.2 years of follow-up, they noted.

Moreover, CVD risk was indeed elevated in these individuals with “unstable” MHO.

“Clearly, therefore, prevention of obesity in the first place is most prudent,” Dr. Deedwania and Dr. Lavie said in their editorial. “Prevention of progressive weight gain over time among the overweight and mildly obese is also of high importance to prevent development of metabolic syndrome and subsequent risk of CVD.”

If individuals with MHO can be identified early, the authors said, there is an excellent opportunity for primary prevention through lifestyle changes, including weight loss and regular physical exercise that might prevent MHO from converting to metabolically unhealthy obesity.

“Such population-wide healthy interventions are the only hope of preventing the oncoming tsunami of metabolic syndrome, diabetes, and CVD,” the editorial authors concluded.

Prakash Deedwania, MD, is with the University of California at San Francisco School of Medicine Program at Fresno. Carl J. Lavie, MD, is with the John Ochsner Heart and Vascular Institute, New Orleans, and the University of Queensland in Brisbane, Australia. These comments are derived from their editorial in the Journal of the American College of Cardiology ( 2018 May 1;71[17]:1866-8) . Both authors reported they had no relevant relationships to disclose.


 

FROM THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Many individuals with metabolically healthy obesity (MHO) will progress to metabolic syndrome over time, putting them at increased risk of cardiovascular disease (CVD), analysis of population-based longitudinal cohort study suggests.

Nearly half of the individuals with MHO developed metabolic syndrome over time, according to the analysis of 6,809 participants followed since the year 2000 in the Multi-Ethnic Study of Atherosclerosis.

Those who developed metabolic syndrome had an increased risk of CVD, compared with those who did not, according to results published in the Journal of the American College of Cardiology.

The results provide new evidence that MHO alone is not a stable or reliable characterization of lower CVD risk, according to Morgana Mongraw-Chaffin, PhD, of the department of epidemiology and prevention at Wake Forest University, Winston-Salem, N.C., and her coauthors.

“Instead, MHO signals an opportunity for weight reduction, and prevention and management of existing metabolic syndrome components should be prioritized,” Dr. Mongraw-Chaffin and her colleagues wrote.

Individuals with MHO, defined in this study as a body mass index of 30 kg/m2 or greater without metabolic syndrome, have a relatively favorable metabolic profile. However, their precise level of CVD risk remains contentious, the investigators noted.

“Although the accumulating evidence is leaning toward the consensus that MHO is not a low-risk state compared with metabolically healthy normal weight, many questions remain about the risk stratification for this group and what causes the heterogeneity seen in the literature,” they wrote.

Pages

Recommended Reading

Bloating. Flatulence. Think SIBO
MDedge Endocrinology
Interleukin-1 antagonist boosts testosterone in obese men
MDedge Endocrinology
VIDEO: It is an exciting time in obesity treatment
MDedge Endocrinology
Obesity in adults continues to rise
MDedge Endocrinology
VIDEO: Adipogenic genes upregulated in high-BMI sucralose users
MDedge Endocrinology
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Endocrinology
Prior bariatric surgery may lead to IBD
MDedge Endocrinology
VIDEO: Intestinal remodeling contributes to HbA1c drop after Roux-en-Y gastric bypass
MDedge Endocrinology
Being overweight as a child increases the risk of developing diabetes
MDedge Endocrinology
Life and health are not even across the U.S.
MDedge Endocrinology